Home > Press > Microfluidics Achieves ISO 9001:2008 Certification
![]() |
Abstract:
Globally Recognized Quality Management System Assures Customers That Appropriate Systems Are In Place To Meet Specialized Needs
Microfluidics International Corporation (OTCBB:MFLU) today announced that its Quality Management System has achieved ISO 9001:2008 certification.
The certification verifies that Microfluidics has effectively applied the ISO 9001 standard to the design, manufacture and distribution of Microfluidizer® high shear fluid processors for pharmaceutical, biotechnology, chemical and allied industries. The certification was provided by United Registrar Services, LLC and authorized through TGA, The German Association for Accreditation GMBH.
"Assuring customers that we focus on understanding their requirements is the most fundamental benefit provided by ISO certification," said Michael C. Ferrara, President and Chief Executive Officer of Microfluidics. "ISO certification is ideal because it is an internationally recognized standard that spans all industries. This independent certification serves as validation that our organization is actively engaged in and committed to quality. Simply put, ISO means 'peace of mind' to customers who understand the value of utilizing a global standard as the basis for their Quality Management System."
Microfluidizer processors are engineered, constructed, customized and shipped by dedicated employees located at the company's global headquarters in Newton, MA. More than 3,000 processors - including the new LV1 Low Volume Microfluidizer processor - are installed at leading pharmaceutical, industrial and academic research institutions in more than 50 countries worldwide.
"The comprehensive approach taken to improvement activities in our Quality Management system fits very well with ISO's expectations for continuous improvement," said Bill Conroy, Senior Vice President of Operations and Engineering at Microfluidics. "Whether it is customer service, product design, production or field service, the same process standards apply for every customer around the world."
To take a virtual tour of the Microfluidics facility in Newton, MA, visit www.microfluidicscorp.com
####
About Microfluidics
Microfluidics (OTCBB: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company's headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.
By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results.
For more information, please click here
Contacts:
Barbara J. Rudolph
Rudolph Communications,LLC
781-229-1811
Copyright © Microfluidics
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
| Related News Press |
News and information
Quantum computer improves AI predictions April 17th, 2026
Flexible sensor gains sensitivity under pressure April 17th, 2026
A reusable chip for particulate matter sensing April 17th, 2026
Detecting vibrational quantum beating in the predissociation dynamics of SF6 using time-resolved photoelectron spectroscopy April 17th, 2026
Microfluidics/Nanofluidics
Projecting light to dispense liquids: A new route to ultra-precise microdroplets January 30th, 2026
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Govt.-Legislation/Regulation/Funding/Policy
Quantum computer improves AI predictions April 17th, 2026
Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||